Report Feature
The future of the genomic market looks promising with opportunities in the research centers, academic and government institutes, hospitals and clinics, and pharmaceutical and biotechnology companies.
The global genomic market is expected to grow with a CAGR of 10% from 2019 to 2024. The major drivers for this market are increasing government funding and growth in the number of genomic projects, decreasing sequencing costs, growing application areas of genomic, and entry of new players and start-ups in the genomic market.A report of more than 150 page is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of genomics market report download the report brochure
The study includes the genomics market size and forecast for the global genomics market through 2024, segmented by product and services, by technology, by application, by end user, and by region as follows:
By Product and Services [$M shipment analysis for 2013 – 2024]:
- Instruments/Systems
- Consumables
- Services
By Technology [$M shipment analysis for 2013 – 2024]:
- Sequencing
- Microarray
- PCR
- Nucleic Acid Extraction and Purification
- Library Preparation
- Data Analysis
- Other Technologies
By Application [$M shipment analysis for 2013 – 2024]:
- Diagnostics
- Drug Discovery and Development
- Precision Medicine
- Agriculture and Animal Research
- Other applications
By End User [$M shipment analysis for 2013 – 2024]:
- Research Centers, Academic and Government Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Other End User
By Region [$M shipment analysis for 2013 – 2024]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
-
Asia-Pacific
- China
- India
- Japan
-
Rest of the World (ROW)
- Brazil
Some of the genomics companies profiled in this report include Illumina, Agilent Technologies, Thermo Fisher Scientific, Eurofins Scientific, Qiagen, GE Healthcare, F. Hoffmann-La Roche, Oxford Nanopore Technologies, Bio-Rad Laboratories, BGI, Eppendorf, Pacific Biosciences, and Danaher.
Some of the features of "Global Genomics Market 2019-2024: Trends, Forecast, and Opportunity Analysis" include
- Market size estimates: Global genomics market size estimation in terms of value ($M) shipment.
- Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
- Segmentation analysis:Global market size by various applications such as by product and services, by technology, by application, by end user, and by region
- Regional analysis:Global genomics market breakdown by North America, Europe, Asia Pacific, and the Rest of the World
- Growth opportunities:Analysis on growth opportunities in different applications and regions for genomics in the global genomics market.
- Strategic analysis:This includes M&A, new product development, and competitive landscape for genomics in the global genomics market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Table of Contents
1. Executive Summary 2. Market Background and Classifications 2.1: Introduction, Background, and Classifications 2.2: Supply Chain 2.3: Industry Drivers and Challenges
7. Company Profiles of Leading Players 7.1: Illumina 7.2: Agilent Technologies 7.3: Thermo Fisher Scientific 7.4: Eurofins Scientific 7.5: Qiagen 7.5: GE Healthcare 7.6: F.Hoffmann-La Roche 7.7: Oxford Nanopore Technologies 7.8: Bio-Rad Laboratories 7.9: BGI 7.10: Eppendorf
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising potential, high-growth opportunities for the global genomic market by product and services (instruments/systems, consumables, and services), technology (sequencing, microarray, PCR (polymerase chain reaction), nucleic acid extraction and purification, library preparation, data analysis, and other ), application (diagnostics, drug discovery and development, precision medicine, agriculture and animal research and others), end user (research centers, academic and government institutes, hospitals and clinics, pharmaceutical and biotechnology companies and others), and region (North America, Europe, Asia-Pacific, Rest of the World(ROW))?
- • Which segments will grow at a faster pace and why?
- • Which regions will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the drivers and challenges of the genomic market?
- • What are the business risks and threats to the genomic market?
- • What are emerging trends in this genomic market and the reasons behind them?
- • What are some changing demands of customers in the genomic market?
- • What are the new developments in the genomic market? Which companies are leading these developments?
- • Who are the major players in this genomic market? What strategic initiatives are being implemented by key players for business growth?
- • What are some of the competitive products and processes in this genomic area and how big of a threat do they pose for loss of market share via material or product substitution?
- • What M & A activities have taken place in the last 5 years in this, genomic market?
